TP53 and neuroendocrine carcinoma: Until recently, only small series have reported TP53 and RB1 alterations in GEP-NEC, and reports are methodologically inconsistent as some studies report gene mutations, others genetic alterations in general and some altered protein levels by immunohistochemistry.